WallStreetZenWallStreetZen

NASDAQ: PRAX
Praxis Precision Medicines Inc Stock Ownership - Who owns Praxis Precision Medicines?

OverviewForecastEarningsRevenueDividendOwnership

Insider buying vs selling

Have Praxis Precision Medicines Inc insiders been buying or selling?

Buy
Sell
NameRoleDateSharesPriceValue
Timothy Edwin KellyChief Financial Officer2026-01-12943$275.74
$260.02kSell
Alex NemiroffGeneral Counsel and Secretary2026-01-12768$275.74
$211.77kSell
Megan SniecinskiChief Operating Officer2026-01-12885$275.74
$244.03kSell
Lauren MastrocolaPrincipal Accounting Officer2026-01-12344$275.74
$94.85kSell
Timothy Edwin KellyChief Financial Officer2026-01-101,335$288.45
$385.08kSell
Marcio SouzaChief Executive Officer2026-01-104,252$288.45
$1.23MSell
Megan SniecinskiChief Operating Officer2026-01-101,087$288.45
$313.55kSell
Alex NemiroffGeneral Counsel and Secretary2026-01-10917$288.45
$264.51kSell
Lauren MastrocolaPrincipal Accounting Officer2026-01-10367$288.45
$105.86kSell
Marcio SouzaChief Executive Officer2026-01-07405$292.63
$118.52kSell

1 of 5

PRAX insiders have sold more... subscribe to Premium to read more.
Net Insider Buy/Sell (L12M) Ownership

Be the first to know when PRAX insiders and whales buy or sell their stock.

PRAX Shareholders

What type of owners hold Praxis Precision Medicines Inc stock?

Institutional
Insider
Retail
NameHoldSharesValueType
Bsof Parallel Master Fund LP17.55%4,894,109$1.69BInsider
Stefan Vitorovic10.54%2,939,329$1.02BInsider
Holdings A. Novo8.76%2,442,080$843.79MInsider
Adage Capital Management LP7.39%2,060,175$711.83MInsider
Vanguard Capital Management LLC4.38%1,221,944$422.21MInstitution
Clarus Lifesciences III LP3.25%907,378$313.52MInsider
Vanguard Portfolio Management LLC2.71%756,748$261.47MInstitution
Kiran Reddy1.68%467,289$161.46MInsider
Pictet Asset Management Holding Sa1.03%286,644$99.04MInstitution
Aberdeen Group PLC0.62%172,484$59.60MInstitution

1 of 3

PRAX vs Biotech Stocks

TickerInst. %Insider %Net Insider (L12M)Net Insider (L3M)
PRAX13.70%50.55%Net Selling
CYTK24.46%12.32%Net SellingNet Selling
BMRN31.66%1.78%Net SellingNet Selling
KRYS21.41%24.13%Net SellingNet Selling
ABVX13.37%0.00%
View Top Biotech Stocks

Praxis Precision Medicines Stock Ownership FAQ

Who owns Praxis Precision Medicines?

Praxis Precision Medicines (NASDAQ: PRAX) is owned by 13.70% institutional shareholders, 50.55% Praxis Precision Medicines insiders, and 35.75% retail investors. Bsof Parallel Master Fund LP is the largest individual Praxis Precision Medicines shareholder, owning 4.89M shares representing 17.55% of the company. Bsof Parallel Master Fund LP's Praxis Precision Medicines shares are currently valued at $1.68B.

If you're new to stock investing, here's how to buy Praxis Precision Medicines stock.
©2026 WallStreetZen
Company
AboutNewsBlogStock Investing FAQPlansPrivacy PolicyTerms of ServiceCancellation & RefundsPerformanceHelp GuidesContactTwitterYouTubeNewsletter
Stock Tools
Top Performing AnalystsStock ScreenerStock ForecastTrending StocksStrong Buy StocksHighest Earnings StocksBest Dividend Paying StocksStatisticsStock Market SectorsStock Market IndustriesHow to Buy Stocks Online
Stock Ideas
Buy The DipBiggest Stock Gainers TodayBiggest Stock Losers Today52 Week High Stocks52 Week Low StocksMost Active Stocks TodayMost Undervalued StocksBest Penny Stocks to Buy NowBest Stocks Under $5Best Stocks Under $10
WallStreetZen does not provide financial advice and does not issue recommendations or offers to buy stock or sell any security.

Information is provided 'as-is' and solely for informational purposes and is not advice. WallStreetZen does not bear any responsibility for any losses or damage that may occur as a result of reliance on this data.